Raymond James Downgrades Hospira (HSP) to Market Perform
Tweet
Share
E-mailGet Alerts HSP Hot Sheet
Price: $89.95 --0%
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 46 | New: 42
Rating Summary:
3 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 46 | New: 42
Join SI Premium – FREE
Raymond James downgraded Hospira (NYSE: HSP) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Hospira click here. For more ratings news on Hospira click here.
Shares of Hospira closed at $30.14 yesterday.
For an analyst ratings summary and ratings history on Hospira click here. For more ratings news on Hospira click here.
Shares of Hospira closed at $30.14 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Sionna Therapeutics (SION) to Market Perform
- Evercore ISI Downgrades Tenax Therapeutics (TENX) to In Line
- Raymond James Downgrades Russel Metals Inc. (RUS:CN) (RUSMF) to Market Perform
Create E-mail Alert Related Categories
DowngradesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
